These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27610752)

  • 1. Surface modulatable nanocapsids for targeting and tracking toward nanotheranostic delivery.
    Stark M; Cheng RH
    Pharm Pat Anal; 2016 Sep; 5(5):307-17. PubMed ID: 27610752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural characterization of site-modified nanocapsid with monodispersed gold clusters.
    Stark MC; Baikoghli MA; Lahtinen T; Malola S; Xing L; Nguyen M; Nguyen M; Sikaroudi A; Marjomäki V; Häkkinen H; Cheng RH
    Sci Rep; 2017 Dec; 7(1):17048. PubMed ID: 29213060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically activatable viral capsid functionalized for cancer targeting.
    Chen CC; Xing L; Stark M; Ou T; Holla P; Xiao K; Kamita SG; Hammock BD; Lam K; Cheng RH
    Nanomedicine (Lond); 2016 Feb; 11(4):377-90. PubMed ID: 26786134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs.
    Wang X; Zhao Q; Dang L; Sun Y; Gao J; Liu B; Syed SF; Tao H; Zhang G; Luo J; Zhou EM
    J Virol; 2015 May; 89(10):5491-501. PubMed ID: 25741007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
    Panda SK; Kapur N; Paliwal D; Durgapal H
    J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic delivery of siRNA by chimeric capsid protein: tumor targeting and RNAi activity in vivo.
    Choi KM; Kim K; Kwon IC; Kim IS; Ahn HJ
    Mol Pharm; 2013 Jan; 10(1):18-25. PubMed ID: 22663765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-viral gene delivery for cancer immunotherapy.
    Wang W; Saeed M; Zhou Y; Yang L; Wang D; Yu H
    J Gene Med; 2019 Jul; 21(7):e3092. PubMed ID: 30991453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery.
    Lee KW; Tey BT; Ho KL; Tejo BA; Tan WS
    Mol Pharm; 2012 Sep; 9(9):2415-23. PubMed ID: 22775561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically engineered and self-assembled oncolytic protein nanoparticles for targeted cancer therapy.
    Lee JJ; Kang JA; Ryu Y; Han SS; Nam YR; Rho JK; Choi DS; Kang SW; Lee DE; Kim HS
    Biomaterials; 2017 Mar; 120():22-31. PubMed ID: 28024232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies.
    Wang K; Kievit FM; Zhang M
    Pharmacol Res; 2016 Dec; 114():56-66. PubMed ID: 27771464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-like nanoparticles as a novel delivery tool in gene therapy.
    Jeevanandam J; Pal K; Danquah MK
    Biochimie; 2019 Feb; 157():38-47. PubMed ID: 30408502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of hepatitis E viral particle.
    Mori Y; Matsuura Y
    Virus Res; 2011 Oct; 161(1):59-64. PubMed ID: 21440590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.
    Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P
    Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of next generation adeno-associated viral vectors capable of selective tropism and efficient gene delivery.
    Zhang C; Yao T; Zheng Y; Li Z; Zhang Q; Zhang L; Zhou D
    Biomaterials; 2016 Feb; 80():134-145. PubMed ID: 26708090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus.
    Li TC; Takeda N; Miyamura T; Matsuura Y; Wang JC; Engvall H; Hammar L; Xing L; Cheng RH
    J Virol; 2005 Oct; 79(20):12999-3006. PubMed ID: 16189002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjugation of paclitaxel on adeno-associated virus (AAV) nanoparticles for co-delivery of genes and drugs.
    Wei F; McConnell KI; Yu TK; Suh J
    Eur J Pharm Sci; 2012 Jun; 46(3):167-72. PubMed ID: 22406091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system.
    Kobayashi T; Takahashi M; Tanggis ; Mulyanto ; Jirintai S; Nagashima S; Nishizawa T; Okamoto H
    J Virol Methods; 2016 Jul; 233():78-88. PubMed ID: 26992654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing sequence plasticity of a virus-like nanoparticle by evolution toward a versatile scaffold for vaccines and drug delivery.
    Lu Y; Chan W; Ko BY; VanLang CC; Swartz JR
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12360-5. PubMed ID: 26392546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interface between hepatitis B virus capsid proteins affects self-assembly, pregenomic RNA packaging, and reverse transcription.
    Tan Z; Pionek K; Unchwaniwala N; Maguire ML; Loeb DD; Zlotnick A
    J Virol; 2015 Mar; 89(6):3275-84. PubMed ID: 25568211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of hepatitis E virus-like particles presenting multiple foreign epitopes by co-infection of recombinant baculoviruses.
    Shima R; Li TC; Sendai Y; Kataoka C; Mori Y; Abe T; Takeda N; Okamoto T; Matsuura Y
    Sci Rep; 2016 Feb; 6():21638. PubMed ID: 26905478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.